US 11155803
Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequence
granted A61PA61P43/00
Quick answer
US patent 11155803 (Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequence) held by Beam Therapeutics Inc. expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Beam Therapeutics Inc.
- Grant date
- Tue Oct 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61P, A61P43/00